UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
+$3.29B |
| 2 |
NVIDIA
NVDA
|
+$2.75B |
| 3 |
Microsoft
MSFT
|
+$2.26B |
| 4 |
Amazon
AMZN
|
+$1.79B |
| 5 |
UnitedHealth
UNH
|
+$1.16B |
Top Sells
| 1 |
Pinduoduo
PDD
|
+$1.19B |
| 2 |
Amphenol
APH
|
+$415M |
| 3 |
Iron Mountain
IRM
|
+$288M |
| 4 |
HDFC Bank
HDB
|
+$211M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$202M |
Sector Composition
| 1 | Technology | 34.77% |
| 2 | Financials | 12.98% |
| 3 | Consumer Discretionary | 11.47% |
| 4 | Healthcare | 10.94% |
| 5 | Communication Services | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Frontline
FRO
$5.03B
| $2.34M | ﹤0.01% |
164,856
+67,445
| +69% | +$957K |
|
1952
Caleres
CAL
$524M
| $2.34M | ﹤0.01% |
100,962
+24,316
| +32% | +$563K |
|
1953
TransAlta
TAC
$3.73B
| $2.31M | ﹤0.01% |
163,491
| – | – |
|
1954
National Vision
EYE
$1.79B
| $2.31M | ﹤0.01% |
221,741
+33,155
| +18% | +$345K |
|
1955
Liquidity Services
LQDT
$838M
| $2.31M | ﹤0.01% |
71,511
+14,542
| +26% | +$470K |
|
1956
Winmark
WINA
$1.71B
| $2.31M | ﹤0.01% |
5,866
-1,194
| -17% | -$469K |
|
1957
Chemours
CC
$2.47B
| $2.29M | ﹤0.01% |
135,423
-19,855
| -13% | -$336K |
|
1958
Par Pacific Holdings
PARR
$1.79B
| $2.29M | ﹤0.01% |
139,623
+11,891
| +9% | +$195K |
|
1959
MoonLake Immunotherapeutics
MLTX
$3.59B
| $2.29M | ﹤0.01% |
42,236
+6,422
| +18% | +$348K |
|
1960
Weis Markets
WMK
$1.74B
| $2.29M | ﹤0.01% |
33,750
+5,199
| +18% | +$352K |
|
1961
BrightView Holdings
BV
$1.31B
| $2.28M | ﹤0.01% |
142,583
+27,148
| +24% | +$434K |
|
1962
Deluxe
DLX
$856M
| $2.28M | ﹤0.01% |
100,719
+13,683
| +16% | +$309K |
|
1963
BrightSpring Health Services
BTSG
$4.93B
| $2.26M | ﹤0.01% |
132,694
+67,634
| +104% | +$1.15M |
|
|
NGD
1964
New Gold Inc
NGD
$5.15B
| $2.26M | ﹤0.01% |
910,656
+7,367
| +0.8% | +$18.3K |
|
1965
Utz Brands
UTZ
$1.1B
| $2.25M | ﹤0.01% |
143,728
+6,268
| +5% | +$98.2K |
|
1966
Rush Street Interactive
RSI
$2.05B
| $2.25M | ﹤0.01% |
163,966
+103,546
| +171% | +$1.42M |
|
1967
Syndax Pharmaceuticals
SNDX
$1.39B
| $2.25M | ﹤0.01% |
170,100
+32,653
| +24% | +$432K |
|
1968
TFS Financial
TFSL
$3.72B
| $2.23M | ﹤0.01% |
177,841
+12,689
| +8% | +$159K |
|
1969
Arbor Realty Trust
ABR
$2.27B
| $2.23M | ﹤0.01% |
161,040
-130,416
| -45% | -$1.81M |
|
|
AAMI
1970
Acadian Asset Management Inc.
AAMI
$1.68B
| $2.22M | ﹤0.01% |
84,399
+22,094
| +35% | +$582K |
|
1971
Thermon Group Holdings
THR
$820M
| $2.22M | ﹤0.01% |
77,269
+9,718
| +14% | +$280K |
|
1972
Viridian Therapeutics
VRDN
$1.66B
| $2.22M | ﹤0.01% |
115,782
+26,286
| +29% | +$504K |
|
1973
Select Water Solutions
WTTR
$899M
| $2.22M | ﹤0.01% |
167,503
+9,188
| +6% | +$122K |
|
|
NVEE
1974
DELISTED
NV5 Global
NVEE
| $2.21M | ﹤0.01% |
117,383
-3,253
| -3% | -$61.3K |
|
1975
XPEL
XPEL
$1.02B
| $2.2M | ﹤0.01% |
55,115
+8,484
| +18% | +$339K |
|